Skip to content

Placebo Oral Solution

DRUG18 trials

Sponsors

UCB BIOSCIENCES, Inc., Ferring Pharmaceuticals, Crinetics Pharmaceuticals Inc., Otsuka Beijing Research Institute, Jazz Pharmaceuticals

Conditions

AutismAutism Spectrum DisorderAutistic DisorderChronic Kidney DiseasesCovid19EndometriosisEpilepsyHealthy

Phase 1

Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers
CompletedNCT03276858
Crinetics Pharmaceuticals Inc.Healthy Volunteers
Start: 2017-09-22End: 2018-04-30Updated: 2018-08-29
A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers
CompletedNCT03936166
Crinetics Pharmaceuticals Inc.Healthy Volunteers
Start: 2019-04-29End: 2019-12-16Updated: 2020-11-04
A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970
CompletedNCT04106297
Galapagos NVHealthy, Psoriasis
Start: 2019-09-10End: 2021-03-05Updated: 2024-09-19
Study on the Safety of the Drug BAY2395840 at Different Doses, the Way the Body Absorbs, Distributes and Excretes the Drug Including the Effect of Its Formulation (Tablet or Liquid) and the Effect of Food on the Absorption, Distribution or Excretion of the Drug in Healthy Male Participants
CompletedNCT05517746
BayerEndometriosis
Start: 2019-12-18End: 2021-03-11Updated: 2022-08-26
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
RecruitingNCT05822544
OrsoBio, IncHealthy Subjects, Obesity, Type 2 Diabetes
Start: 2023-04-22End: 2026-06-30Target: 564Updated: 2025-12-18
Single and Multiple-Ascending Dose Study of CRN04894 in Healthy Volunteers
CompletedNCT06048887
Crinetics Pharmaceuticals Inc.Healthy Volunteers
Start: 2020-12-18End: 2022-04-11Updated: 2023-09-21
CBD for Pain Following Orthopedic Shoulder Surgery
RecruitingNCT06381791
The Methodist Hospital Research InstituteRotator Cuff Injuries, Shoulder Osteoarthritis
Start: 2024-05-24End: 2027-12-30Target: 80Updated: 2026-03-18
A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects
RecruitingNCT07300189
OrsoBio, IncHealthy Participants
Start: 2025-10-20End: 2026-12-01Target: 288Updated: 2026-01-30

Phase 2

Phase 3

Unknown Phase

Related Papers

13 more papers not shown